Первичные новообразования легких у собак. Часть 1.
Онкология

Первичные новообразования легких у собак. Часть 1.

Сравнительные характеристики

Автор: Сейлиев Д. А., ветеринарный врач-хирург, онколог Ветеринарной клиники Сотникова, г. Санкт-Петербург.

Первичные новообразования легких встречаются у кошек и собак не так часто, как вторичные метастатические поражения легочной ткани (вторичные или метастатические новообразования легких, фото 3). По этой причине речь в статье пойдет именно о первичных новообразованиях, но с разными клиническими проявлениями.


Список литературы:
  1. Brodey RS, Craig PH. Primary pulmonary neoplasms in the dog: a review of 29 cases, J Am Vet Med Assoc 147:1628–1643, 1965. 
  2. Nielsen SW, Horava A. Primary pulmonary tumors of the dog. A report of sixteen cases, Am J Vet Res 21:813–830, 1960. 
  3. Moulton JE, von Tscharner C, Schneider R. Classification of lung carcinomas in the dog and cat, Vet Pathol 18:513–528, 1981. 
  4. D’Costa S, Yoon B-I, Kim DY, et al. Morphologic and molecular analysis of 39 spontaneous feline pulmonary carcinomas, Vet Pathol, 2011. 
  5. Dorn CR, Taylor DO, Frye FL, et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases, J Natl Cancer Inst 40:295–305, 1968.
  6. Dobson JM, Samuel S, Milstein H, et al. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs, J Small Anim Pract 43:240–246, 2002. 
  7. Hahn FF, Muggenburg BA, Griffith WC. Primary lung neoplasia in a beagle colony, Vet Pathol 33:633–638, 1996. 
  8. Griffey SM, Kraegel SA, Madewell BR. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis, Carcinogenesis 19:959–963, 1998. 
  9. Stunzi H, Head KW, Nielsen SW. Tumours of the lung, Bull World Health Organ 50:9–19, 1974.
  10. Meuten DJ. Tumors in domestic animals, ed 4, Ames, Iowa, 2002, Iowa State University Press.
  11. McNiel EA, Ogilvie GK, Powers BE, et al. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992),  J Am Vet Med Assoc 211:1422–1427, 1997. 
  12. Mehlhaff CJ, Leifer CE, Patnaik AK, et al. Surgical treatment of primary pulmonary neoplasia in 15 dogs, J Am Anim Hosp Assoc 20:5, 1984. 
  13. Ogilvie GK, Haschek WM, Withrow SJ, et al. Classification of primary lung tumors in dogs: 210 cases (1975-1985), J Am Vet Med Assoc 195:106–108, 1989. 
  14. Paoloni MC, Adams WM, Dubielzig RR, et al. Comparison of results of computed tomography and radiography with histopathologic findings in tracheobronchial lymph nodes in dogs with primary lung tumors: 14 cases (1999-2002), J Am Vet Med Assoc 228:1718–1722, 2006. 
  15. Brodey RS. Hypertrophic osteoarthropathy in the dog: a clinicopathologic survey of 60 cases, J Am Vet Med Assoc 159:1242– 1256, 1971. 
  16. Halliwell WH, Ackerman N. Botryoid rhabdomyosarcoma of the urinary bladder and hypertrophic osteoarthropathy in a young dog, J Am Vet Med Assoc 165:911–913, 1974. 
  17. Caywood DD, Kramek BA, Feeney DA, et al. Hypertrophic osteopathy associated with a bronchial foreign body and lobar pneumonia in a dog, J Am Vet Med Assoc 186:698–700, 1985. 
  18. Liptak JM, Monnet E, Dernell WS, et al. Pulmonary metastatectomy in the management of four dogs with hypertrophic osteopathy, Vet Comp Oncol 2:1–12, 2004. 
  19. Grillo TP, Brandao CV, Mamprim MJ, et al. Hypertrophic osteopathy associated with renal pelvis transitional cell carcinoma in a dog, Can Vet J 48:745–747, 2007. 
  20. Hawkins EC, DeNicola DB, Plier ML. Cytological analysis of bronchoalveolar lavage fluid in the diagnosis of spontaneous respiratory tract disease in dogs: a retrospective study, J Vet Intern Med 9:386–392, 1995. 
  21. Liptak JM, Monnet E, Dernell WS, et al. Pneumonectomy, four case studies and a comparative review, J Small Anim Prac 45:441–447, 2004. 
  22. DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology, ed 8, Philadelphia, 2008, Wolters Kluwer/Lippincott Williams & Wilkins.
  23. Ogilvie GK, Reynolds HA, Richardson RC, et al. Phase II evaluation of doxorubicin for treatment of various canine neoplasms, J Am Vet Med Assoc 195:1580–1583, 1989. 
  24. Ogilvie GK, Obradovich JE, Elmslie RE, et al. Efficacy of mitoxantrone against various neoplasms in dogs, J Am Vet Med Assoc 198:1618–1621, 1991. 
  25. Poirier VJ, Burgess KE, Adams WM, et al. Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia, J Vet Intern Med 18:536–539, 2004. 
  26. Chabner B, Longo DL. Cancer chemotherapy and biotherapy: principles and practice, ed 4, Philadelphia, 2006, Lippincott Williams & Wilkins. 
  27. Hershey AE, Kurzman ID, Forrest LJ, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model, Clin Cancer Res 5:2653–2659, 1999. 
  28. Khanna C, Vail DM. Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers, Curr Cancer Drug Targets 3:265–273, 2003.
  29. London CA, Hannah AL, Zadovoskaya R, et al. Phase I dose- escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies, Clin Cancer Res 9:2755–2768, 2003. 
  30. Ahrar K, Price RE, Wallace MJ, et al. Percutaneous radiofrequency ablation of lung tumors in a large animal model, J Vasc Interv Radiol 14:1037–1043, 2003. 
  31. Muller H, Guadagni S. Regional chemotherapy for carcinoma of the lung, Surg Oncol Clin N Am 17:895–917, 2008. 
  32. Van Putte BP, Grootenboers M, van Boven WJ, et al. Selective pulmonary artery perfusion for the treatment of primary lung cancer: Improved drug exposure of the lung, Lung Cancer 65:208–213, 2009. 
  33. Ogilvie GK, Weigel RM, Haschek WM, et al. Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975-1985), J Am Vet Med Assoc 195:109–112, 1989. 
  34. Polton GA, Brearley MJ, Powell SM, et al. Impact of primary tumour stage on survival in dogs with solitary lung tumours, J Small Anim Pract 49:66–71, 2008. 
  35. Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends, Cancer Epidemiol Biomarkers Prev 19:1893–1907, 2010. 
  36. G. Polton, R. Finotello, S. Sabattini, F. Rossi, P. Laganga, M. E. Vasconi, A. Barbanera, K. Stiborova, C. Rohrer Bley, L. Marconato. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide. Vet Comp Oncol. September 2018;16(3):399-408.
  37. Rose SC, Thistlethwaite PA, Sewell PE, et al. Lung cancer and radiofrequency ablation, J Vasc Interv Radiol 17:927–951; quiz 951, 2006. 
  38. Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors, Cardiovasc Intervent Radiol 31:122–130, 2008. 
  39. Crocetti L, Lencioni R. Radiofrequency ablation of pulmonary tumors, Eur J Radiol 75:23–27, 2010. 
  40. Duncan M, Wijesekera N, Padley S. Interventional radiology of the thorax, Respirology 15:401–412, 2010.
  41. Grootenboers MJ, Schramel FM, van Boven WJ, et al. Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of pulmonary malignancies, Lung Cancer 63:400–404, 2009. 
  42. Poirier VJ, Burgess KE, Adams WM, et al: Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia, J Vet Intern Med 18:536–539, 2004.